We close the gap between your growth and enterprise value

Most healthcare companies we work with aren't struggling to grow. They're struggling to make that growth story legible to boards, to buyers, and to themselves. Our Enterprise Value Creation System™ is the commercialization process that closes that gap.

Flowchart titled 'The Enterprise Value Creation System' illustrating six steps: 1. Value Gap, 2. Diagnose, 3. Architect, 4. Engine, 5. Evaluate, 6. Realize. Each step includes descriptions related to enterprise growth, system building, and value creation, culminating in capturing value through timing, narrative, and readiness.

THE PROBLEM WE SOLVE

Growth that can't be explained can't be scaled. Growth that can't be scaled can't be sold.

When revenue grows faster than the business that supports it, a gap opens. It's not visible on a dashboard. That gap has a name: the enterprise value gap. It's the most expensive problem in most mid-market healthcare companies because by the time it becomes obvious at a valuation, the leverage to fix it is already gone.

Learn more about the sectors we specialize in

It shows up in:

Board meetings that feel harder than they should.

Sales cycles that stretch without a clear reason.

Diligence conversations where the numbers look right but the story doesn't land.

THE SYSTEM

The Enterprise Value Creation System™

The EVCS™ is a proprietary six-stage framework that maps the path from growth pressure to realized enterprise value. Each stage represents a structural lever — a place where value is either built or quietly lost.

01

Stage 01

Value Gap

Growth and enterprise value don't move together automatically. Over time, a gap opens between what the business is producing and what it's actually worth. Most teams don't see it until diligence makes it visible to everyone at once. Stage 1 identifies where the divergence starts and what's driving it.

02

Stage 02

Exit Readiness

Most companies that fail to achieve target valuation are uneven ones. Strength in one area masks weakness in another until scrutiny hits. Stage 2 maps alignment across the five dimensions buyers and boards use to assess readiness, and surfaces the gaps before they surface in the wrong conversation.

03

Stage 03

Commercial System

When marketing, sales, and product operate independently, friction is the only thing that scales. Stage 3 builds the structural connections that make growth coordinated, repeatable, and legible to buyers, not just visible on a growth chart.

04

Stage 04

Value Flywheel

The best builders connect what they fix to how they go to market. Improved outcomes strengthen positioning. Stronger positioning attracts better customers. Better customers fund continued investment. Stage 4 creates the reinforcing loop that turns good quarters into compounding enterprise value.

05

Stage 05

Buyer Lens

Buyers don't reward effort. They reward evidence. Before they look at your financials, they're already forming a view based on clarity, consistency, and proof of performance. Stage 5 aligns the business to how sophisticated buyers actually evaluate risk, so the story holds when the room gets serious.

06

Stage 06

Exit Outcome

The exit is won long before the process begins. Stage 6 captures the value built across the preceding stages through timing, narrative architecture, and diligence-ready positioning, so the offer reflects what the business has actually built, not just what buyers can see on the surface.

Explore the full EVCS framework

WHO THIS IS FOR

Built for mid-market healthcare and pharmacy leaders where growth has started to outpace value

Legacy DNA works with PE-backed, VC-backed, and founder-led pharmacy and healthtech companies at the inflection points where standard fixes stop working.

$10M–$250M

in revenue

100–1,000

employees

12–36 mo

to exit or capital event

The common thread isn't stage or sector. It's the moment: when the board is asking harder questions, when growth exists but isn't compounding, when the story that got the business here isn't holding up the way it should for the current stage.

See who we work with

Six headshots of women in different settings, smiling and looking at the camera.

Senior-led. Not delegated.

Legacy DNA is a small, senior-led firm. We work with a limited number of companies each year — by design. Every engagement is led directly by Dr. Roxie Mooney and senior team members with direct healthcare exit experience. There is no junior handoff, no account management layer, and no project team you haven't met.

Enterprise healthcare ‍ ‍ Regulated environments ‍ ‍ Board-level communications ‍ ‍ PE-backed execution

Diagram showing a process for strategic fit call with sections labeled as Your Personalized Analysis, Exit Readiness Score, and Vision, Impact, and Value Creation, with icons of a magnifying glass, gear, lightbulb, DNA, and AI.

YOUR NEXT STEP

Schedule your Strategic Fit Call

It’s a practical conversation to determine whether the Enterprise Value Creation System™ fits your situation and what will most effectively strengthen your valuation.

No pitch. No pressure. Just clarity.